Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Seligdar reported for 2022 according to IFRS
4/28/23
SELG
Board of Directors of Nornickel recommends shareholders not to pay dividends for 2022
4/28/23
GMKN
Stavropolenergosbyt reported for 3 months of 2023 by RAS
4/28/23
STSB
LSR sales in Q1 decreased by 26% in physical terms and by 36% in monetary terms
4/28/23
LSRG
Norilsk Nickel reported for 3 months of 2023 by RAS
4/28/23
GMKN
En+ Group would like to give up without penalties higher-priced TPP modernization projects
4/28/23
ENPG
RusHydro commissioned Krasnogorsk small HPPs
4/28/23
HYDR
Himprom reported for 3 months of 2023 by RAS
4/28/23
HIMCP
IDGC of Urals reported for 3 months of 2023 by RAS
4/28/23
MRKU
Colgate reports 3 months of 2023
4/28/23
CL
«
Previous
631
632
633
634
635
636
637
638
639
640
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)